Treatment options in type-2 low asthma

Treatment options in type-2 low asthma

Monoclonal antibodies targeting IgE or the type-2 cytokines IL-4, IL-5 and IL-13 are proving highly effective in reducing exacerbations and symptoms in people with severe allergic and eosinophilic asthma respectively. However, these therapies are not appropriate for 30–50% of patients in severe asth...

書誌詳細
主要な著者:	Hinks, TSC, Levine, SJ, Brusselle, GG
フォーマット:	Journal article
言語:	English
出版事項:	European Respiratory Society 2020

類似資料

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
著者:: Couillard, S, 等
出版事項: (2021)

Non-typeable Haemophilus influenzae airways infection: the next treatable trait in asthma?
著者:: Hinks, TSC, 等
出版事項: (2022)

Boosting MAIT cells as immunotherapy: Context is everything
著者:: Hinks, TSC
出版事項: (2020)

Azithromycin for mild-to-moderate COVID-19 - Authors' reply
著者:: Hinks, TSC
出版事項: (2021)

A proof-of-concept scale to predict asthma attacks: the OxfoRd Asthma attaCk risk ScaLE (ORACLE)
著者:: Couillard, S, 等
出版事項: (2021)

ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma—implications for COVID-19
著者:: Bradding, P, 等
出版事項: (2020)

Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis
著者:: Oliver, ME, 等
出版事項: (2021)

Is there a role for type 2 CD8+ T cells in patients with steroid-resistant asthma?
著者:: Gelfand, EW, 等
出版事項: (2019)

Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma
著者:: Couillard, S, 等
出版事項: (2021)

Azithromycin in viral infections
著者:: Oliver, ME, 等
出版事項: (2020)

Small airways in asthma: treatment options
著者:: K. A. Zykov
出版事項: (2013-12-01)

MAIT cells and the microbiome
著者:: Jabeen, MF, 等
出版事項: (2023)

Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment
著者:: Lavoie, G, 等
出版事項: (2024)

The upper and lower airway microbiome in severe asthma
著者:: Jabeen, M, 等
出版事項: (2022)

Unconventional Treatment Options in Severe Asthma: An Overivew
著者:: Hoan Linh Banh
出版事項: (2011-10-01)

Biological treatment options for severe asthma in Poland
著者:: Maciej Superson, 等
出版事項: (2024-05-01)

Azithromycin in uncontrolled asthma
著者:: Brusselle, G, 等
出版事項: (2017)

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
著者:: Crossingham, I, 等
出版事項: (2020)

Treatment options for severe bronchial asthma: reality and prospects
著者:: N. M. Nenasheva
出版事項: (2013-12-01)

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids while on monoclonal antibody therapy: protocol for a prospective observational study (BOOST)
著者:: Howell, I, 等
出版事項: (2023)

Biological functions of MAIT cells in tissues
著者:: Klenerman, P, 等
出版事項: (2020)

Editorial: MAIT cells come of age
著者:: Corbett, AJ, 等
出版事項: (2023)

Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
著者:: Hinks, T, 等
出版事項: (2017)

Biological treatment of severe asthma: new objectives and new treatment options
著者:: N. M. Nenasheva
出版事項: (2019-12-01)

Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
著者:: Kumar, K, 等
出版事項: (2020)

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
著者:: Couillard Castonguay, S, 等
出版事項: (2022)

Severe asthma and the omalizumab option
著者:: Johnston Chambless, 等
出版事項: (2008-05-01)

New targets for type 2-low asthma
著者:: Quang Luu Quoc, 等
出版事項: (2024-03-01)

High-altitude sojourn: a treatment option in allergic asthma
著者:: Swiss Medical Weekly
出版事項: (2013-07-01)

Severe refractory asthma: current treatment options and ongoing research
著者:: Francesco Menzella, 等
出版事項: (2018-12-01)

From spirometry to spatial omics in pursuit of asthma endotypes
著者:: Hinks, T
出版事項: (2022)

New therapy options for patients with eosinophilic type of severe bronchial asthma
著者:: G. L. Ignatova, 等
出版事項: (2020-01-01)

Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
著者:: Crossingham, I, 等
出版事項: (2021)

Chronic orchialgia: evaluation and discussion of treatment options
著者:: Laurence Levine
出版事項: (2010-10-01)

CD8+ Tc2 cells: underappreciated contributors to severe asthma
著者:: Hinks, T, 等
出版事項: (2019)

Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
著者:: Crossingham, I, 等
出版事項: (2021)

Tiotropium as an Add-on Treatment Option for Severe Uncontrolled Asthma in Preschool Patients
著者:: Zielen S, 等
出版事項: (2021-01-01)

Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
著者:: Dorey-Stein ZL, 等
出版事項: (2021-01-01)

The role of interleukin-17 in asthma: a protective response?
著者:: Hynes, G, 等
出版事項: (2020)

From spirometry to spatial omics in pursuit of asthma endotypes
著者:: Timothy S. C. Hinks
出版事項: (2022-09-01)